Mesenchymal stem cells and regenerative medicine - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Médecine/Sciences Année : 2018

Mesenchymal stem cells and regenerative medicine

Cellules souches mésenchymateuses et médecine régénératrice


Mesenchymal stromal or stem cells (MSCs) are multipotent adult cells that can be isolated from a variety of adult or neonatal tissues, such as bone marrow, fat tissue, placenta or umbilical cord. A therapy based on MSCs can be justified in osteoarthritis (OA) thanks to their differentiation abilities but mostly, to their paracrine and immunosuppressive properties. Possible therapeutic strategies therefore rely on the articular injection of MSCs suspensions for trophic activity or the implantation of MSCs combined with biodegradable materials for tissue engineering applications. Depending on the mode of administration and behavior after implantation, they can decrease local inflammation, prevent chondrocyte hypertrophy and apoptosis as well as differentiate into cartilage-forming chondrocytes. In this review, we summarize pathophysiological and mechanistic data and discuss perspectives confirming the interest of MSCs as a potential therapeutic strategy in OA.
Fichier principal
Vignette du fichier
msc170210.pdf (1.47 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02307298 , version 1 (07-10-2019)



Marie Maumus, Yves-Marie Pers, Maxime Ruiz, Christian Jorgensen, Danièle Noël. Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis.. Médecine/Sciences, 2018, 34 (12), pp.1092-1099. ⟨10.1051/medsci/2018294⟩. ⟨hal-02307298⟩
146 Consultations
237 Téléchargements



Gmail Mastodon Facebook X LinkedIn More